Treatment with SR18662 substantially lessens development and proliferation of CRC cells. SR18662 displays improved efficacy in lowering viability of several CRC cell traces. Movement cytometry Investigation following SR18662 treatment method demonstrates an increase in cells captured in both S or G2/M phases with the cell cycle and a significant increase https://zbigniewr641ins4.wikiconverse.com/user